Home Clinical Topics Cardio-Pulmonary FDA approves Impavido to treat leishmaniasis

FDA approves Impavido to treat leishmaniasis

On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here